TBC1D10C: A Potential Drug Target and Biomarker for Chronic Pain

Target Name: TBC1D10C

NCBI ID: G374403

TBC1D10C

TBC1D10C: A Potential Drug Target and Biomarker for Chronic Pain

Introduction

Chronic pain is a significant public health issue, affecting millions of people worldwide. The constant and severe pain can have a significant impact on an individual's quality of life, leading to reduced mobility, decreased productivity, and an increased risk of depression and anxiety. In In addition, chronic pain can also have a significant economic burden, with individuals experiencing chronic pain spending an average of $63 billion annually on healthcare costs.

The search for new treatments for chronic pain has led to the development of various drugs and therapies, but many of these approaches have limitations. For example, opioids, which are commonly used to treat chronic pain, can have severe side effects, such as addiction and overdose. Additionally, nonsteroidal anti-inflammatory drugs (NSAIDs) can cause stomach ulcers and bleeding, which can be life-threatening.

TBC1D10C, a protein known as a potential drug target and biomarker for chronic pain, has the potential to revolutionize the treatment of chronic pain. Its unique structure and function make it an attractive target for drug developers.

Structure and Function

TBC1D10C is a protein that is expressed in various tissues and cells in the body, including the brain, spinal cord, and peripheral tissues. It is a member of the TBC1 family of proteins, which are involved in the regulation of pain signaling. TBC1D10C is composed of 194 amino acids and has a molecular weight of 21 kDa.

TBC1D10C has been shown to play a critical role in pain signaling and has the potential to modulate pain perception. Studies have shown that TBC1D10C is involved in the regulation of pain signals in the brain and that it can interact with other proteins involved in pain signaling.

Potential Drug Target

TBC1D10C has the potential to be a drug target for chronic pain because of its involvement in pain signaling. By modulating the activity of TBC1D10C, researchers may be able to reduce pain perception or alleviate the symptoms of chronic pain. This could be achieved through a variety of mechanisms, such as blocking the action of pain-causing molecules or modulating the activity of pain-sensitive neurons.

In addition, TBC1D10C may also be a useful biomarker for tracking the effectiveness of pain treatments. By measuring the levels of TBC1D10C in the body, researchers can determine whether a treatment is effective in reducing pain. This could be a valuable tool for monitoring the effectiveness of new pain treatments and could help to reduce the time and resources required for drug development.

Biomarker Potential

TBC1D10C has the potential to serve as a biomarker for chronic pain. Studies have shown that TBC1D10C levels are significantly elevated in individuals with chronic pain, compared to individuals without chronic pain. Additionally, TBC1D10C levels have been shown to be associated with the severity of chronic pain. pain.

While more research is needed to fully understand the potential role of TBC1D10C as a biomarker for chronic pain, these findings suggest that it may be a valuable tool for tracking the effectiveness of pain treatments.

Conclusion

TBC1D10C is a protein with the potential to revolutionize the treatment of chronic pain. Its unique structure and function make it an attractive target for drug developers, and its potential as a biomarker for chronic pain makes it an important area of 鈥嬧?媟esearch. Further studies are needed to fully understand the role of TBC1D10C in pain signaling and its potential as a drug target and biomarker for chronic pain.

Protein Name: TBC1 Domain Family Member 10C

Functions: Inhibits the Ras signaling pathway through its intrinsic Ras GTPase-activating protein (GAP) activity. Acts as a negative feedback inhibitor of the calcineurin signaling pathway that also mediates crosstalk between calcineurin and Ras

The "TBC1D10C Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TBC1D10C comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets